Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction | Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Gorovitz Aarondirector |
Buy | 35,000 @ $0.32 | $11,197 | 105,000 | 08/30/2023 | 09/11/2023 | |
Hurvitz Chaimdirector |
Buy | 70,000 @ $0.29 | $20,125 | 570,000 | 08/30/2023 | 09/11/2023 | |
Gorovitz Aarondirector |
Buy | 35,000 @ $0.32 | $11,197 | 105,000 | 08/30/2023 | 09/11/2023 | |
Hurvitz Chaimdirector |
Buy | 70,000 @ $0.29 | $20,125 | 570,000 | 08/30/2023 | 09/11/2023 | |
Javitt Jonathan Cdirector, 10 percent owner, Chief Scientist |
Buy | 100,000 @ $0.33 | $33,000 | 446,332 | 08/23/2023 | 08/24/2023 | |
Javitt Jonathan Cdirector, 10 percent owner, Chief Scientist |
Buy | 100,000 @ $0.33 | $33,000 | 446,332 | 08/23/2023 | 08/24/2023 | |
Javitt Jonathan Cdirector, 10 percent owner, Chief Scientist |
Buy | 200,000 @ $0.32 | $64,400 | 346,332 | 08/22/2023 | 08/23/2023 | |
Javitt Jonathan Cdirector, 10 percent owner, Chief Scientist |
Buy | 200,000 @ $0.32 | $64,400 | 346,332 | 08/22/2023 | 08/23/2023 | |
Willard Stephen Hdirector: CHIEF EXECUTIVE OFFICER |
Buy | 50,000 @ $1.17 | $58,500 | 50,000 | 12/16/2022 | 12/19/2022 | |
VAN VOORHEES SETHdirector: CHIEF FINANCIAL OFFICER |
Buy | 30,000 @ $1.10 | $33,000 | 46,337 | 12/16/2022 | 12/19/2022 | |
Willard Stephen Hdirector: CHIEF EXECUTIVE OFFICER |
Buy | 50,000 @ $1.17 | $58,500 | 50,000 | 12/16/2022 | 12/19/2022 | |
VAN VOORHEES SETHdirector: CHIEF FINANCIAL OFFICER |
Buy | 30,000 @ $1.10 | $33,000 | 46,337 | 12/16/2022 | 12/19/2022 | |
Javitt Jonathan Cdirector |
Sell | 400,000 @ $1.00 | $400,000 | 12,899,997 | 12/07/2022 | 12/09/2022 | |
Javitt Jonathan Cdirector |
Sell | 400,000 @ $1.00 | $400,000 | 12,899,997 | 12/07/2022 | 12/09/2022 | |
Javitt Daniel C.director |
Sell | 8,441 @ $1.50 | $12,700 | 9,634,793 | 11/30/2022 | 12/01/2022 | |
Javitt Daniel C.director |
Sell | 8,441 @ $1.50 | $12,700 | 9,634,793 | 11/30/2022 | 12/01/2022 | |
Javitt Daniel C.director |
Sell | 13,730 @ $1.50 | $20,651 | 9,643,234 | 11/29/2022 | 12/01/2022 | |
Javitt Daniel C.director |
Sell | 13,730 @ $1.50 | $20,651 | 9,643,234 | 11/29/2022 | 12/01/2022 | |
Flynn Patrick Johndirector |
Buy | 2,500 @ $1.25 | $3,125 | 37,709 | 11/28/2022 | 11/29/2022 | |
Flynn Patrick Johndirector |
Buy | 1,750 @ $1.25 | $2,188 | 1,750 | 11/28/2022 | 11/29/2022 |
Member of congress | Current Price | Type | Trade Data | Date Filed | Date Traded |
---|
A. The list of insiders at NRx Pharmaceuticals, Inc. includes Javitt Jonathan C, Hurvitz Chaim, Gorovitz Aaron.
A. Insiders have purchased a total of 810,000 NRx Pharmaceuticals, Inc. shares in the last 12 months for a total of 257,443 sold.
A. The following insiders have purchased NRx Pharmaceuticals, Inc. shares in the last 12 months: Javitt Jonathan C ($194,800), Hurvitz Chaim ($40,250), Gorovitz Aaron ($22,393),